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The glycogen-binding (G) subunit of protein phosphatase-I is phosphorylated in vivo. In rabbits injected with propranol- 
01 the serine residue termed site-l was phosphorylated in 56% of the molecules isolated, and phosphorylation increased 
to 8296 after administration of adrenalin. It is concluded that the G-subunit is a physiological substrate for cyclic AMP- 
dependent protein kinase. The G-subunit remained largely bound to glycogen even after injection of adrenalin, whereas 
half of the protein phosphatase-1 activity associated with glycogen was released into the cytosoi. The results indicate 
that adrenalin induces dissociation of the catalytic subunit from the G-subunit in viva. 
Protein phosphatase: Glycogen; Adrenalin; Phosphopeptide; Cellular regulation 
1. INTRODUCTION 
Three forms of protein phosphatase-1 (PP-1) 
have been identified in rabbit skeletal muscle, an 
inactive cytosolic form (PP-11) [ 1,2] and two active 
forms that are bound to glycogen (PP-lo) [3,4] 
and myosin (PP-1~) [5,6]. Each form contains a 
very similar, if not identical, catalytic subunit 
(PP-lc) complexed to an inhibitory subunit, 
inhibitor-2 (PP-lr), a glycogen-binding subunit 
(PP-lo) or a myosin-binding subunit (PP-1~). 
The undegraded glycogen-binding (G) subunit 
of PP-lo has an apparent molecular mass of 
161 kDa (Hubbard, M. and Cohen, P., in prepara- 
tion) and appears to have a regulatory as well as a 
targetting function. It is phosphorylated very 
rapidly by cyclic AMP-dependent protein kinase 
(A-kinase) in vitro [3] and the primary structure 
surrounding the major phosphoserine residue 
(termed site-l) reveals the characteristic Arg-Arg- 
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X-Ser- sequence [7] commonly found at the 
phosphorylation sites of physiological substrates 
for A-kinase (reviewed in [8]). Phosphorylation of 
the G-subunit in vitro does not seem to alter the ac- 
tivity of PP-lo directly, but increases the rate at 
which it can be inactivated by inhibitor-l (I-l) [3] 
and decreases the proportion of PP-1~ that can be 
sedimented with glycogen [9]. Consistent with the 
latter finding, injection of adrenalin in vivo 
decreases the amount of PP-1 activity in skeletal 
muscle extracts that sediments with glycogen- 
protein particles from ~70% to =35%, and in- 
creases activity in the cytosol by a similar amount 
[9]. These observations suggest that translocation 
of PP-1 from glycogen to cytosol occurs in 
response to adrenalin, and may provide a 
mechanism for preventing dephosphorylation of 
the glycogen metabolising enzymes (glycogen 
phosphorylase and glycogen synthase) which re- 
main tightly bound to glycogen even after ad- 
ministration of adrenalin [9]. In this paper we 
demonstrate that the G-subunit is phosphorylated 
at site-l in vivo and that phosphorylation of this 
serine residue increases in response to adrenalin. 
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2. MATERIALS AND METHODS 
2.1. Isolation of protein phosphatase-lo after injection of 
propranolol or adrenalin 
Rabbits were injected with propranolol (2 m&kg) 10 min 
prior to a lethal dose of sodium pentobarbital, or with adrenalin 
(0.25 mg in 10 mM ascorbic acid) injected together with pen- 
tobarbital and skeletal muscle (2000 g) from the hind limbs and 
back of three animals was homogenised under conditions that 
preserve the phosphorylation states of the glycogen metabolis- 
ing enzymes. The entire procedure was carried out as described 
for glycogen synthase up to and including isolation of the 
glycogen-protein particles [lo], except that a second protein 
phosphatase inhibitor (1 mM NazP207) was added to all solu- 
tions in addition to 50 mM NaF, and the muscle extracts were 
adjusted to pH 5.7, rather than 5.9, to precipitate the glycogen- 
protein particles. PP-lo was purified from glycogen-protein 
particles as in [4] except that NaCl concentrations were reduced 
by 50 mM to accommodate the NaF. The enzyme was located 
by assaying for phosphorylase phosphatase activity [ll], but 
with inclusion of 1 mM MnClz to reactivate the NaF and 
NazPzO,-inactivated phosphatase [9], while the G-subunit was 
located by immunoblotting using the antibody described below. 
The G-subunit copurified with phosphatase activity at every 
stage and stepwise elution from each anion-exchange column 
(except the final chromatography on Mono Q) was employed to 
avoid selective purification of either the phosphorylated or 
dephosphorylated protein. For this reason, the final prepara- 
tions were only 50-70% pure, but this did not interfere with 
subsequent isolation of the tryptic phosphopeptide. 
2.2. Antibody to the G-subunit 
The 103 kDa G’-fragment of PP-lo (1.5 mg) [4] was excised 
from an SDS-polyacrylamide gel, lyophilised and powdered. It 
was emulsified with Freund’s incomplete adjuvant and 0.5 mg 
injected subcutaneously into a sheep at multiple sites. This pro- 
cedure was repeated twice more over nine weeks before 
bleeding. The y-globulin fraction was isolated by fractionation 
with ammonium sulphate, dissolved in 50 mM Tris-HCI, pH 
7.5 (O”C), 0.15 M NaCl, dialysed against this buffer and stored 
at -20°C. 
3. RESULTS 
As reported in [9], the proportion of PP-1 activi- 
ty in muscle extracts that could be sedimented with 
glycogen-protein particles was found to decrease 
from 265% to ~35% following intravenous injec- 
tion of adrenalin, with a corresponding increase in 
the cytosolic content of the enzyme (table 1). 
However, Western blotting experiments using a 
polyclonal antibody directed against the G- 
subunit, revealed that this protein was mainly 
located in the glycogen-protein particles, even after 
injection of adrenalin, and the cytosolic content 
was not increase by this hormone (fig. 1). This im- 
plies that PP-IC is dissociated from the G-subunit 
in response to adrenalin, a finding that is con- 
sidered further in section 4. 
Protein phosphatase lo (2-4 mg, purity 
50-70%), isolated from propranolol or adrenalin- 
treated rabbits in the presence of protein 
phosphatase inhibitors (see section 2), was mixed 
with 0.02 mg of 32P-labelled PP-lo (SO- 
100000 cpm) that had been phosphorylated in 
vitro by A-kinase and freed from [y-32P]ATP as in 
[7]. This trace of marker protein enabled the 
Table 1 
Phosphate content of the site-l tryptic peptide after injection of propranolol or adrenalin 
Preparation Injection Phosphate content 
(mol/mol) 
Analysis Area 
Phosphate activity 
Va) 
pH 5.7 pm pH 5.7 supt 
I 
2 
3 
Av (+ SE) 
4 
5 
6 
Av (+ SE) 
propranolol 0.48 0.53 
propranolol 0.57 0.56 
propranolol 0.64 0.62 
propranolol 0.56 f 0.08 0.57 f 0.05 
adrenalin 0.76 0.75 
adrenalin 0.85 0.87 
adrenalin ND 0.87 
adrenalin 0.81 +_ 0.04 0.83 + 0.08 
64 36 
62 38 
67 33 
64 + 3 36 + 3 
27 73 
37 63 
22 78 
29 + 8 71 + 8 
Phosphorylation stoichiometries were calculated by quantitative amino acid analysis 
(analysis) of the phosphopeptide and dephosphopeptide (fig.2) and by integration of the areas 
under each peak (area). ND, not determined. Phosphorylase phosphatase activities were 
measured in the pH 5.7 precipitate and pH 5.7 supernatant in the presence of 1 mM MnClz 
as in [9] 
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G)O3-- c-97 
Fig. 1. Localisation of the glycogen-binding subunit by Western 
blotting. Rabbit skeletal muscle extracts (50 ml) were adjusted 
to pH 5.7, and after centrifugation the supernatants were 
decanted, and the pH 5.7 precipitates containing the glycogen- 
protein particles were redissolved in 50 ml of 50 mM Tris-HCI, 
pH 7.5 (O”C), 1 mM EDTA, 10% (v/v) glycerol, 0.1% (v/v) 
2-mercaptoethanol, 1 mM benzamidine, 0.1 mM 
phenylmethylsulphonyl fluoride, 50 mM sodium fluoride, 
1 mM sodium pyrophosphate. The pH 5.7 supernatant and 
resuspended pH 5.7 precipitate (10 ~1) were each denatured in 
2 pl of 10% SDS at 100°C and subjected to polyacrylamide gel 
electrophoresis 1171. The gel was transferred ta nitrocellulose 
and the G-subunit located by Western blotting with the 
polyclonal antibody as in [18]. No bands were observed if the 
antibody was replaced by preimmune immunoglobulin (not 
shown). The arrows denote the positions of the undegraded G- 
subunit (161 kDa) and the proteolytic G’-subfragment 
(103 kDa) and the marker proteins myosin (205 kDa) and 
phosphorylase (97 kDa). Lanes 1 and 3 show the pH 5.7 
precipitates from adrenalin and propranolol-treated animals, 
containing 12 and 25 gU of phosphorylase phosphatase 
activity, respectively, and lanes 2 and 4 the pH 5.7 supernatants 
from adrenalin and propranolol-treated animals, containing 21 
and 13 pU of phosphorylase phosphatase activity, respectively. 
purification of the peptide to be followed and 
recoveries to be calculated. The native protein was 
cleaved with trypsin to release the site-l 
phosphopeptide, which was purified by gel filtra- 
tion on Sephadex G50 and reverse-phase 
chromatography on a Vydac Crs column 
equilibrated in 0.1% (v/v) trifluoroacetic acid 
(TFA) as in [7]. The overall recovery was 5060%. 
The 32P-labelled peptide was eluted as a single ma- 
P n u 
propranolol 1 
P 
adrenalin 
A 
0 AA- 
60 42 44 46 
time (mini 
Fig.2. Reverse-phase chromatography at pH 6.5 of the site-l 
tryptic peptide. The tryptic peptide obtained by reverse-phase 
chromatography on the Vydac cl8 column equilibrated in 0.1% 
TFA (see text and [7]) was pooled, dried, redissolved in 10 mM 
ammonium acetate, pH 6.5, and rechromatographed on the 
Vydac column equilibrated in the same solvent. The column 
was developed with a linear acetonitrile gradient, with an 
increase in acetonitrile concentration of 0.36% per min. The 
flow rate was 1 ml/min and fractions of 0.5 ml were collected. 
The peptide was resolved into the phospho-(P) and dephospho- 
(D) forms, which were eluted at 11.5 and 12% acetonitrile, 
respectively. The yield of peptide (P + D) was 80%. 
jor peak from both columns, and coincided on the 
Vydac column with a major peak of 206 nm absor- 
bance. The elution position of this peak (18% 
acetonitrile) and its amino acid composition were 
the same as the 19 residue site-l tryptic peptide 
isolated previously [7]. 
Phosphopeptides are usually eluted at 
acetonitrile concentrations OS- 1% lower than 
their dephosphorylated counterparts from Crs col- 
umns run in 0.1% TFA [ 12,131, but amino acid 
analysis of fractions eluting after the 32P- 
radioactivity failed to detect any further material 
that might have corresponded to the 
dephosphopeptide. The peptide that coincided 
with the 32P-radioactivity was therefore pooled, 
dried and resubjected to reverse-phase 
chromatography on the Vydac column at pH 6.5, 
as described in the legend to fig.2. Two major 
peaks of 214 nm absorbance were eluted from the 
column, and termed P and D. Peak P was eluted 
at 11.5% acetonitrile and coincided with the 32P- 
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marker, while peak D eluted = 1.5 min later at 12% 
acetonitrile. The amino acid compositions of peaks 
P and D were identical, except for the presence of 
an additional arginine residue in peak P (table 2). 
Fast atom bombardment mass spectrometry of the 
two peaks using a VG 250s machine established 
that peak P (MH+ = 2075) was a 
monophosphorylated erivative of the site-l tryp- 
tic peptide isolated previously [7], while peak D 
(MH+ = 1839) was the dephosphopeptide lacking 
one of the two arginines present in peak P. 
the tryptic phosphopeptide. Thus phosphorylation 
of serine-3 prevented tryptic cleavage of the Arg- 
Gly bond between positions 1 and 2, as observed 
for other phosphorylation sites of A-kinase 
[ 15,161. The phospho- and dephosphopeptides 
I- 
In order to locate the position of the 
phosphorylated residue(s), peaks P and D were in- 
cubated with NaOH and ethanethiol to convert 
phosphoserine residues to S-ethylcysteine [12,14] 
and analysed on a gas-phase sequencer. These ex- 
periments revealed that the N-terminal sequence of 
peak D was Gly-Ser-Glu-Ser-Ser-Glu-, while that 
of peak P was Arg-Gly-S-ethylCys-Glu-Ser-Ser- 
Glu- (fig.3). Identical results were obtained with 
peptides isolated from propranolol or adrenalin- 
treated animals. This established that serine-3 was 
the site of phosphorylation in peak P, and that 
peak D lacked the N-terminal arginine residue of 
s OTT-S 
d- 
0 
S OTT-S 11 
Table 2 
5 DTT-S S OTT-S 
Amino acid compositions of peaks P and D from fig.2 
Amino acid 
Asp 
Glu 
Ser 
C]Y 
His 
Arg 
Thr 
Ala 
Pro 
Tyr 
Val 
Met 
Ile 
Leu 
Phe 
LYS 
Peak P 
2.12 (3) 
5.23 (5) 
3.26 (3) 
0.83 (1) 
2.15 (2) 
1.26 (1) 
1.00 (1) 
0.74 (1) 
1.58 (2) 
Peak D 
2.59 (3) 
5.06 (5) 
3.36 (3) 
0.76 (1) 
1.05 (1) 
1.10 (1) 
1.00 (1) 
0.74 (1) 
1.59 (2) 
Time (minutes I 
Fig.3. Sequence analysis of site-l tryptic peptides after 
incubation with NaOH and ethanethiol. Following incubation 
with NaOH and ethanethiol [12], the reactions were terminated 
by addition of acetic acid and the solution dried. The residues 
were washed twice with water, redissolved in 0.1% TFA and 
passed through a Hamilton ‘miniclean’ C-18 cartridge. After 
elution of non-peptide material, peptides were eluted with 50% 
acetonitrile in 0.1% TFA, dried and analysed on an Applied 
Biosystems 470 gas-phase sequencer equipped with an on-line 
model 120 PTH-analyser. The figure shows reverse-phase 
chromatograms of PTH-derivatives corresponding to residues 
2-5 of the dephosphopeptide (D2-D5) and 3-6 of the 
phosphopeptide (P33P6). The amounts applied to the 
sequencer were approx. 350 pmol. The ultraviolet absorbance 
scale is O-0.014 (D) and O-0.025 (P). Serine was detected by the 
appearance of two peaks, namely PTH-Ser itself (S) and its 
dithiothreitol adduct (DTT-S). Abbreviations: S, serine; C, 
glycine; E, glutamic acid; S-EtC, S-ethylcysteine. a,b and c 
represent dithiothreitol, dimethylphenylthiourea and 
diphenylthiourea, respectively. The glycine present in D2 and 
Total 19 18 
Peptides were hydrolysed for 16 h at 110°C and analysed using 
a Waters PICOTAG system as in [19]. Values for serine and 
threonine were corrected for 10% and 5% destruction, 
respectively, and impurities below 0.2 residues are omitted. 
Numbers in parentheses show values expected from the 
sequence analysis given in [7] P3 is carried over from the previous cycle. 
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presumably coelute during reverse-phase 
chromatography in TFA because the effect of the 
phosphoryl group to increase effective 
hydrophilicity and decrease retention time is 
counterbalanced by the presence of an additional 
arginine residue which increases effective 
hydrophobicity. At pH 6.5, the extra negative 
charge on phosphoserine ensures its elution at an 
acetonitrile concentration lower than the 
dephosphopeptide, despite the presence of one 
more arginine. 
The relative amounts of the phospho- and 
dephosphopeptides were determined by quan- 
titative amino acid analysis as well as by integra- 
tion of the areas under the 214 nm absorbance 
peaks (fig.2). The results showed that the molar 
proportion of phosphopeptide : dephosphopeptide 
was about 1: 1 in animals injected with pro- 
pranolol and increased to nearly 5 : 1 after injection 
of adrenalin (table 1, fig.2). 
The activity ratio T glucosedP of glycogen syn- 
thase was measured in glycogen-protein particles 
of the same preparations to check the efficacy of 
the hormone treatments. The activity ratios in 
animals injected with propranolol and adrenalin 
were 0.19 f 0.01 and 0.04 f 0.01, respectively 
(both + SE for 3 preparations). These values are 
almost identical to those reported previously using 
the same assay system [lo]. 
4. DISCUSSION 
In this paper we have established that the G- 
subunit of PP-lo is phosphorylated at site-l in 
vivo and that its degree of phosphorylation in- 
creases in response to adrenalin, indicating that the 
G-subunit is a physiological substrate for A- 
kinase. Assuming equal recovery of the 
phosphorylated and dephosphorylated species 
throughout the protein and peptide purifications, 
the phosphorylation stoichiometries were 
0.56 mol/mol (propranolol) and 0.82 mol/mol 
(adrenalin) (table 1). 
The effect of adrenalin to release PP-lc from 
the glycogen-protein particles is only observed if 
skeletal muscle is homogenised in the presence of 
protein phosphatase inhibitors [9], indicating that 
one or more phosphorylation events are required 
to promote dissociation from the G-subunit. 
However, it is not yet certain whether phosphory- 
lation of site-l alone is responsible for dissocia- 
tion. If this was the case, the phosphorylated 
G-subunit associated with glycogen-protein par- 
ticles should not be complexed to PP-I,_-. Alter- 
natively, the G-subunit, like glycogen synthase 
[20], is phosphorylated at multiple sites by several 
kinases, increased phosphorylation at several posi- 
tions being required to promote dissociation. 
Another possibility is that phosphorylation of 
site-l (and/or other sites) weakens the interaction 
between PP-lc and the G-subunit sufficiently to 
allow a cytosolic protein to extract PP-1~ from the 
G-subunit. In this connection, it should be noted 
that the apparent molecular mass of PP-I in the 
cytosol is > 100 kDa both before and after injec- 
tion of adrenalin (Hiraga, A., unpublished), in- 
dicating that PP-lc binds to another protein upon 
its release from the glycogen-protein particles. The 
identity of this protein is currently under in- 
vestigation. 
It is also surprising that site-l is phosphorylated 
to at least 0.5 mol/mol in propranolol-treated 
animals. The residue on muscle glycogen synthase 
phosphorylated most rapidly by A-kinase in vitro, 
which also has the sequence Arg-Arg-X-Ser, is not 
phosphorylated at all under these conditions [20]. 
This suggests that the G-subunit may be 
dephosphorylated extremely slowly in resting mus- 
cle, so that phosphorylation is still substantial even 
when A-kinase activity is very low. Alternatively, 
site-l may be phosphorylated in vivo by an addi- 
tional enzyme distinct from A-kinase. 
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